Newly Approved Targeted Drug Makes 79% Of Patients' Tumours Disappear Altogether, This Type Of Blood Tumour Is Saved!
Shonan Kamakura General Hospital
More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy!
Does a Full Stomach Really Hurt Your Brain?
FDA Approves Vabysmo, The First Bispecific Antibody For The Eye!
Pre-Operative Immunotherapy And More Than Half Of The Tumours In This Type Of Skin Cancer Disappear Completely!
